•
BB
BBNX
Beta Bionics, Inc. Common Stock
polygonSURGICAL & MEDICAL INSTRUMENTS & APPARATUS
--
Price Chart
Market Cap
725.09M
Volume
352.19K
52W High
$32.71
52W Low
$8.89
Open
$16.63
Prev Close
$16.47
Day Range
16.19 - 17.60
About Beta Bionics, Inc. Common Stock
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.
Latest News
Scott+Scott Attorneys at Law LLP Alerts Investors of Its Investigation Into Beta Bionics, Inc. (NASDAQ: BBNX)
GlobeNewswire Inc.•19h ago
Beta Bionics, Inc. Investigated on Behalf of Investors - Contact the DJS Law Group to Discuss Your Rights - BBNX
Benzinga•Jan 15
BBNX Investors Have Opportunity to Join Beta Bionics, Inc. Fraud Investigation with the Schall Law Firm
GlobeNewswire Inc.•Jan 14
Securities Fraud Investigation Into Beta Bionics, Inc. (BBNX) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
Benzinga•Jan 12
Beta Bionics, Inc. Investigated on Behalf of Investors - Contact the DJS Law Group to Discuss Your Rights – BBNX
Benzinga•Jan 12
BBNX Investors Have Opportunity to Join Beta Bionics, Inc. Fraud Investigation with the Schall Law Firm
Benzinga•Jan 10
Global Artificial Pancreas Devices Market is Gearing Up for Outstanding Expansion at a CAGR of ~16% by 2032 | DelveInsight
GlobeNewswire Inc.•Jun 18
Goldman Sachs Bullish On Dexcom And Insulet As Diabetes Tech Surges
Benzinga•Jun 2